Medicus Pharma shareholders approve board authority for up to 1-for-50 share consolidation

• Medicus Pharma held its annual general and special meeting on June 3, 2026.
• Shareholders ratified KPMG LLP as independent registered public accounting firm for fiscal 2026; the board was authorized to set fees and terms.
• Shareholders approved a special resolution authorizing the board to consolidate common shares, at its discretion, up to a 50-for-1 ratio.
• The share consolidation was authorized but not executed; any consolidation remains subject to a separate board determination on timing and ratio.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medicus Pharma Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001062993-26-003060), on June 04, 2026, and is solely responsible for the information contained therein.